Search research articles
Contact Us
Filters
Showing results (41-50 of 82) with videos related to
Page
of 9
Sort By:
Nature Clinical Practice. Oncology
|
January 13, 2006
Gefitinib response of erlotinib-refractory lung cancer involving meninges--role of EGFR mutation
Nicholas W Choong, Sascha Dietrich, Tanguy Y Seiwert, et al.
The American Journal of Surgical Pathology
|
August 19, 2004
Expression of alpha-methylacyl-coenzyme A racemase in nephrogenic adenoma
Anita Gupta, Hanlin L Wang, Maria Luisa Policarpio-Nicolas, et al.
American Journal of Clinical Pathology
|
February 18, 2005
Overexpression of glutathione s-transferase alpha in clear cell renal cell carcinoma
Shang-Tian Chuang, Peiguo Chu, Jun Sugimura, et al.
The American Journal of Surgical Pathology
|
July 15, 2004
Expression of RON Proto-oncogene in Renal Oncocytoma and Chromophobe Renal Cell Carcinoma
Kurt T Patton, Maria S Tretiakova, Jorge L Yao, et al.
Cancer Cell
|
June 10, 2015
ERG Activates the YAP1 Transcriptional Program and Induces the Development of Age-Related Prostate Tumors
Liem T Nguyen, Maria S Tretiakova, Mark R Silvis, et al.
Cancer
|
February 26, 2004
Gene expression profiling of renal medullary carcinoma: potential clinical relevance
Ximing J Yang, Jun Sugimura, Maria S Tretiakova, et al.
Cancer Research
|
February 20, 2007
c-Met overexpression is a prognostic factor in ovarian cancer and an effective target for inhibition of peritoneal dissemination and invasion
Kenjiro Sawada, A Reza Radjabi, Nariyoshi Shinomiya, et al.
Genes, Chromosomes & Cancer
|
August 19, 2008
Expression and mutational analysis of MET in human solid cancers
Patrick C Ma, Maria S Tretiakova, Alexander C MacKinnon, et al.
The Journal of Biological Chemistry
|
April 3, 2010
EphA2 mutation in lung squamous cell carcinoma promotes increased cell survival, cell invasion, focal adhesions, and mammalian target of rapamycin activation
Leonardo Faoro, Patrick A Singleton, Gustavo M Cervantes, et al.
Oncotarget
|
October 21, 2016
Mismatch repair deficiency may be common in ductal adenocarcinoma of the prostate
Michael T Schweizer, Heather H Cheng, Maria S Tretiakova, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 82) with videos related to
Sort By:
Page
of 9
Nature Clinical Practice. Oncology
|
January 13, 2006
Gefitinib response of erlotinib-refractory lung cancer involving meninges--role of EGFR mutation
Nicholas W Choong, Sascha Dietrich, Tanguy Y Seiwert, et al.
The American Journal of Surgical Pathology
|
August 19, 2004
Expression of alpha-methylacyl-coenzyme A racemase in nephrogenic adenoma
Anita Gupta, Hanlin L Wang, Maria Luisa Policarpio-Nicolas, et al.
American Journal of Clinical Pathology
|
February 18, 2005
Overexpression of glutathione s-transferase alpha in clear cell renal cell carcinoma
Shang-Tian Chuang, Peiguo Chu, Jun Sugimura, et al.
The American Journal of Surgical Pathology
|
July 15, 2004
Expression of RON Proto-oncogene in Renal Oncocytoma and Chromophobe Renal Cell Carcinoma
Kurt T Patton, Maria S Tretiakova, Jorge L Yao, et al.
Cancer Cell
|
June 10, 2015
ERG Activates the YAP1 Transcriptional Program and Induces the Development of Age-Related Prostate Tumors
Liem T Nguyen, Maria S Tretiakova, Mark R Silvis, et al.
Cancer
|
February 26, 2004
Gene expression profiling of renal medullary carcinoma: potential clinical relevance
Ximing J Yang, Jun Sugimura, Maria S Tretiakova, et al.
Cancer Research
|
February 20, 2007
c-Met overexpression is a prognostic factor in ovarian cancer and an effective target for inhibition of peritoneal dissemination and invasion
Kenjiro Sawada, A Reza Radjabi, Nariyoshi Shinomiya, et al.
Genes, Chromosomes & Cancer
|
August 19, 2008
Expression and mutational analysis of MET in human solid cancers
Patrick C Ma, Maria S Tretiakova, Alexander C MacKinnon, et al.
The Journal of Biological Chemistry
|
April 3, 2010
EphA2 mutation in lung squamous cell carcinoma promotes increased cell survival, cell invasion, focal adhesions, and mammalian target of rapamycin activation
Leonardo Faoro, Patrick A Singleton, Gustavo M Cervantes, et al.
Oncotarget
|
October 21, 2016
Mismatch repair deficiency may be common in ductal adenocarcinoma of the prostate
Michael T Schweizer, Heather H Cheng, Maria S Tretiakova, et al.
Page
of 9